Improving Outcomes for Hemodialysis Patients

Completed · Not applicable

Conditions studied: Quality of Life, End Stage Renal Disease

In brief

End stage renal disease (ESRD) affects approximately 700,000 Americans of which approximately 400,000 are on life-saving hemodialysis therapy. Hemodialysis can take a physical and emotional toll on patients, and most patients on hemodialysis describe poor quality of life. Patients on hemodialysis have worse health related quality of life (HrQOL) than patients with any other chronic illness including cancer and congestive heart failure. This poor quality of life can affect how well these patients manage their own health or their self-care, and can ultimately lead to poor health outcomes. Despite this, there are no commonly used programs to improve quality of life or self-care for patients on hemodialysis. The investigators have developed a simple 3-step program to improve quality of life and self-care for patients on hemodialysis. The first step involves presenting quality of life scores to the dialysis health care team so that a program can be designed. The second step involves 8-12 education sessions combined with behavioral training designed to improve quality of life and self-care. The final step is monthly re-evaluation of progress. In this study, the investigators will test this 3-step program, compared to dialysis education alone, to see if it improves quality of life and self-care. By improving quality of life and self-care the investigators believe patient outcomes including hospitalizations will improve.

Key facts

Study ID

NCT03395366

Run by

Columbia University

People needed

48

Starts

2018-05-01

Expected to finish

2020-04-28

Last updated by the study team

2022-03-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients on hemodialysis for at least 3 months
• Most recent 36-question Kidney Disease Quality of Life (KDQOL-36), Physical Component Summary (PCS), or Mental Component Summary (MCS) score below 50
• KDQOL-36 burden of disease score 80
• Expected survival 6 months
• English-speaking

You may not qualify if…

• Bipolar or Psychotic disorder
• Moderate or severe cognitive impairment as determined by the hemodialysis staff or documented in the electronic medical record (EMR)
• Severe vision or hearing impairment
• Drug or alcohol dependence
• Active suicidal ideation or a history of suicide attempt (determined based on screening patient health questionnaire-9 and EMR)
• Current participation in a behavioral or education treatment program

Where it is running

• DaVita Columbia University Dialysis — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.